Ethan Perlstein

Ethan Perlstein, founder of Perlara PBC, San Francisco, CA, a biotech startup focused on precision orphan drug discovery. Dr. Perlstein received his Ph.D. in molecular and cell biology from Harvard University, and was a Lewis-Sigler Fellow at Princeton University. He is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Participating years: 2016, 2017, 2018